FLT3 and acute myeloid leukemia: These findings suggest that AML development in our model is unlikely due to increased self-renewal of HSCs/HPCs, in contrast to that in NPM1c/FLT3-ITD and FLT3-ITD/Dnmt3a mutant mice [22, 23].